-
COMPARING THE DISEASE BURDEN OF MIGRAINE BETWEEN USERS OF CGRP MONOCLONAL ANTIBODIES AND PREVENTIVE GEPANTS
Mar 18, 2026, 21:38 PM -
QUALITY FIRST: MODERNIZING THE NURSING CURRICULUM FOR ACCREDITED HEALTHCARE
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF MONOTHERAPY VS. COMBINATION THERAPY FOR HIV MANAGEMENT INDIA PERSPECTIVE: A MARKOV MODEL ANALYSIS
Mar 18, 2026, 21:38 PM -
EVALUATING ANALGESIC EFFICACY USING BUCHER AND ANCHORED MATCHING-ADJUSTED INDIRECT COMPARISON: A COMPARISON OF ANRIKEFON AND TEGILERIDINE
Mar 18, 2026, 21:38 PM -
ESTIMATING THE FINANCIAL IMPACT OF DUPILUMAB FOR COPD USING REAL-WORLD CLAIMS DATA: A PROBABILISTIC BUDGET IMPACT ANALYSIS IN THE BRAZILIAN PRIVATE HEALTH SYSTEM
Mar 18, 2026, 21:38 PM -
SOCIAL AND STRUCTURAL DETERMINANTS OF BUPRENORPHINE ADHERENCE AMONG INDIVIDUALS WITH OPIOID USE DISORDER
Mar 18, 2026, 21:38 PM -
ECONOMIC IMPACT OF CANCER-RELATED PRODUCTIVITY LOSSES IN HIGH-INCOME AND MIDDLE-INCOME ASIA-PACIFIC MARKETS: TRENDS FROM 2010 TO 2022
Mar 18, 2026, 21:38 PM -
EARLY EXPERIENCE WITH THE EUROPEAN UNION JOINT CLINICAL ASSESSMENT (EUJCA): IMPLICATIONS FOR ONCOLOGY PRODUCTS
Mar 18, 2026, 21:38 PM -
BRIDGING HER2 TESTING AND TREATMENT: REAL-WORLD EVIDENCE ACROSS 22 SOLID TUMORS
Mar 18, 2026, 21:38 PM -
THE COST OF INEQUITY: ESTIMATING THE IMPACT OF DELAYED ACCESS TO NEOADJUVANT PERTUZUMAB IN CANADA
Mar 18, 2026, 21:38 PM -
COMPARATIVE EFFECTIVENESS OF AUGMENTATION, SWITCHING, AND DOSE ESCALATION AFTER INADEQUATE ANTIDEPRESSANT RESPONSE IN MEDICARE BENEFICIARIES
Mar 18, 2026, 21:38 PM -
BAYESIAN MULTI-PARAMETER EVIDENCE SYNTHESIS FOR INFORMED EXTRAPOLATIONS OF TIME-TO-EVENT OUTCOMES IN MULTISTATE MODELS
Mar 18, 2026, 21:38 PM -
NATIONWIDE COVID-19 TESTING PATTERNS AND DISPARITIES IN POSITIVITY AND ANTIVIRAL TREATMENT IN A U.S. RETAIL PHARMACY CHAIN, SEPTEMBER-DECEMBER 2025
Mar 18, 2026, 21:38 PM -
AVAILABILITY, PRICES, AND AFFORDABILITY OF ESSENTIAL MEDICINES FOR CARDIOVASCULAR DISEASES AND DIABETES: A MULTI-REGIONAL SURVEY ACROSS PAKISTAN
Mar 18, 2026, 21:38 PM -
REAL-WORLD MULTIPLE MYELOMA TREATMENT RESPONSES: EVALUATION OF FRONTLINE REGIMENS IN MELDTM LINKED MEDICARE, LABORATORY AND ELECTRONIC MEDICAL RECORDS...
Mar 18, 2026, 21:38 PM -
IMPACT OF TIME-VARYING RELAPSE RISK ON LONG-TERM COST-EFFECTIVENESS OUTCOMES IN CHRONIC RELAPSING DISEASES
Mar 18, 2026, 21:38 PM -
UNCOVERING EVIDENCE GAPS IN THE CLINICAL, ECONOMIC, AND HUMANISTIC IMPACT OF DUCHENNE MUSCULAR DYSTROPHY: A COMPREHENSIVE LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
SYSTEMATIC SYNTHESIS OF DIRECT EBOLA OUTBREAK RESPONSE COSTS FOR COST-EFFECTIVENESS MODELLING
Mar 18, 2026, 21:38 PM -
HEALTHCARE UTILIZATION PATTERNS AMONG MEDICARE BENEFICIARIES WITH FINANCIAL CONSTRAINTS
Mar 18, 2026, 21:38 PM -
DETERMINANTS OF DELAY IN EGFR INHIBITOR INITIATION AND ITS IMPACT ON CLINICAL OUTCOMES IN NON-SMALL CELL LUNG CANCER PATIENTS
Mar 18, 2026, 21:38 PM
